IMNPQ's free cash flow for Q was $-1.53M. For the fiscal year, IMNPQ's free cash flow was decreased by $741.00K and operating cash flow was $-1.50M. See a summary of the company’s cash flow.

Cash Flow	TTM	Dec 17	Dec 16	Dec 15	Dec 14	Dec 13
Operating Cash Flow	$ -14.69M	$ -11.56M	$ -12.31M	$ -13.91M	$ -13.86M	$ -3.87M
Investing Cash Flow	$ -105.00K	$ 31.00K	$ -50.00K	$ -177.00K	$ 117.00K	$ -1.13M
Financing Cash Flow	$ 14.79M	$ 18.03M	$ 8.09M	$ 11.86M	$ 20.46M	$ 4.95M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 11.09M	$ 6.78M	$ 271.00K	$ 4.54M	$ 6.77M	$ 49.00K
Income Tax Paid Supplemental Data	-	$ 0.00	$ 81.00K	$ 0.00	$ 0.00	$ 7.00K
Interest Paid Supplemental Data	$ 1.00K	$ 156.00K	$ 416.00K	$ 378.00K	$ 505.00K	$ 173.00K
Issuance Of Capital Stock	$ 16.04M	$ 16.04M	$ 5.27M	$ 12.00M	$ 11.03M	$ 4.37M
Issuance Of Debt	$ 2.11M	$ 2.89M	$ 2.46M	$ 4.50M	$ 11.17M	$ 123.00K
Repayment Of Debt	$ -3.19M	$ -5.33M	$ -1.60M	$ -3.19M	$ -1.49M	$ -37.00K
Free Cash Flow	$ -14.79M	$ -11.59M	$ -12.33M	$ -14.07M	$ -13.89M	$ -3.87M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Immune Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing